JP2008527041A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008527041A5 JP2008527041A5 JP2007552198A JP2007552198A JP2008527041A5 JP 2008527041 A5 JP2008527041 A5 JP 2008527041A5 JP 2007552198 A JP2007552198 A JP 2007552198A JP 2007552198 A JP2007552198 A JP 2007552198A JP 2008527041 A5 JP2008527041 A5 JP 2008527041A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- aryl
- heterocyclyl
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64493405P | 2005-01-19 | 2005-01-19 | |
| PCT/US2006/001483 WO2006078598A2 (en) | 2005-01-19 | 2006-01-13 | Mitotic kinesin inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008527041A JP2008527041A (ja) | 2008-07-24 |
| JP2008527041A5 true JP2008527041A5 (enExample) | 2009-02-26 |
Family
ID=36692770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007552198A Withdrawn JP2008527041A (ja) | 2005-01-19 | 2006-01-13 | 有糸分裂キネシン阻害剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20090124641A1 (enExample) |
| EP (1) | EP1855685A4 (enExample) |
| JP (1) | JP2008527041A (enExample) |
| CN (1) | CN101106998A (enExample) |
| AU (1) | AU2006206675A1 (enExample) |
| CA (1) | CA2593166A1 (enExample) |
| WO (1) | WO2006078598A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR068890A1 (es) * | 2007-11-07 | 2009-12-16 | Schering Corp | Compuestos para inhibir la actividad quinesina ksp |
| US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| WO2015051244A1 (en) | 2013-10-04 | 2015-04-09 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| US9751888B2 (en) | 2013-10-04 | 2017-09-05 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| EP3119397B1 (en) | 2014-03-19 | 2022-03-09 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders |
| WO2016054491A1 (en) | 2014-10-03 | 2016-04-07 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| CN114230571B (zh) | 2015-09-14 | 2025-07-08 | 无限药品股份有限公司 | 异喹啉酮的固体形式、其制备方法、包含其的组合物及其使用方法 |
| US10759806B2 (en) | 2016-03-17 | 2020-09-01 | Infinity Pharmaceuticals, Inc. | Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors |
| US10919914B2 (en) | 2016-06-08 | 2021-02-16 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| CN113549000A (zh) * | 2020-04-23 | 2021-10-26 | 复旦大学 | 用于预防或治疗脂质代谢相关疾病的化合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4183931A (en) * | 1977-09-08 | 1980-01-15 | Research Corporation | 2-Ketoalkyl-4(3H)-quinazolinones |
| US5470975A (en) * | 1990-10-16 | 1995-11-28 | E.R. Squibb & Sons, Inc. | Dihydropyrimidine derivatives |
| US6667300B2 (en) * | 2000-04-25 | 2003-12-23 | Icos Corporation | Inhibitors of human phosphatidylinositol 3-kinase delta |
| US20070149500A1 (en) * | 2003-01-17 | 2007-06-28 | Han-Jie Zhou | Compounds, compositions, and methods |
| JP2007510660A (ja) * | 2003-11-07 | 2007-04-26 | サイトキネティクス・インコーポレーテッド | 化合物、組成物及び方法 |
-
2006
- 2006-01-13 EP EP06718541A patent/EP1855685A4/en not_active Withdrawn
- 2006-01-13 JP JP2007552198A patent/JP2008527041A/ja not_active Withdrawn
- 2006-01-13 CA CA002593166A patent/CA2593166A1/en not_active Abandoned
- 2006-01-13 US US11/795,448 patent/US20090124641A1/en not_active Abandoned
- 2006-01-13 CN CNA2006800025464A patent/CN101106998A/zh active Pending
- 2006-01-13 WO PCT/US2006/001483 patent/WO2006078598A2/en not_active Ceased
- 2006-01-13 AU AU2006206675A patent/AU2006206675A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008527038A5 (enExample) | ||
| Ruch et al. | Hedgehog signaling pathway and cancer therapeutics: progress to date | |
| RU2468021C2 (ru) | Гетероциклические соединения и их применение | |
| JP2009514881A5 (enExample) | ||
| JP2022017295A5 (enExample) | ||
| Sahebjam et al. | The utility of hedgehog signaling pathway inhibition for cancer | |
| JP2007517071A5 (enExample) | ||
| EP4161511A1 (en) | Novel small molecules for targeted degradation of untargetable kras in cancer therapy | |
| JP2018504418A5 (enExample) | ||
| US20090054415A1 (en) | Combinations, methods and compositions for treating cancer | |
| Jin et al. | Curaxin CBL0137 exerts anticancer activity via diverse mechanisms | |
| JP7182304B2 (ja) | インドリノン化合物の使用 | |
| JP2009541223A5 (enExample) | ||
| RU2008122048A (ru) | Аминопиримины в качестве ингибиторов киназ | |
| NZ580009A (en) | Combination therapies comprising quinoxaline inhibitors of pi3k-alpha for use in the treatment of cancer | |
| RU2002120515A (ru) | Гетероциклические соединения, содержащие сульфонамидные группы | |
| JP2015520753A5 (enExample) | ||
| Abdelaleem et al. | Prospects for repurposing CNS drugs for cancer treatment. | |
| RU2017104909A (ru) | Лечение рака комбинацией лучевой терапии, наночастиц оксида церия и химиотерапевтического средства | |
| Dai et al. | Small molecule inhibitors targeting cyclin-dependent kinases as anticancer agents | |
| JP2008527041A5 (enExample) | ||
| JP2008527039A5 (enExample) | ||
| JP2020523354A5 (enExample) | ||
| MX2007004549A (es) | Tratamiento combinado con bortezomib y un inhibidor de cinasa del receptor del factor de crecimiento epidermico. | |
| JPWO2020163823A5 (enExample) |